OLMA

NASDAQ · Biotechnology

Olema Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.34

+0.58 (+8.58%)

As of Nov 7, 1:42 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +129.0% upside

Low Target $15.48

Average Target $16.81

High Target $21.94

Current Price $7.34

Current
$7.34

Target
$16.81

$15.48 $16.81 avg $21.94

Scenario Analysis

Bear Case

$15.48

110.9%

Low target

Base Case

$16.81

+129.0%

Avg target

Bull Case

$21.94

+198.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$36.26

-79.8% from high

52-Week Low

$6.24

+17.7% from low

Target vs 52W High

$16.81

-53.6% vs high

Next Earnings Report

Nov 10, 2026

until earnings

EPS Est: $-0.64

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%